Carl Aure Sells 2,746 Shares of Lifevantage Corporation (NASDAQ:LFVN) Stock

Lifevantage Corporation (NASDAQ:LFVN - Get Free Report) CFO Carl Aure sold 2,746 shares of the firm's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $13.39, for a total value of $36,768.94. Following the sale, the chief financial officer directly owned 133,303 shares of the company's stock, valued at approximately $1,784,927.17. This represents a 2.02% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Lifevantage Price Performance

NASDAQ LFVN traded down $0.88 on Friday, reaching $12.53. 56,986 shares of the company's stock traded hands, compared to its average volume of 155,472. Lifevantage Corporation has a 12 month low of $5.22 and a 12 month high of $27.38. The stock has a 50-day simple moving average of $12.56 and a 200 day simple moving average of $15.91. The stock has a market cap of $157.69 million, a PE ratio of 18.15 and a beta of 0.43.

Lifevantage (NASDAQ:LFVN - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.10. The firm had revenue of $58.44 million during the quarter, compared to the consensus estimate of $60.99 million. Lifevantage had a return on equity of 34.67% and a net margin of 4.12%.

Lifevantage Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Friday, May 30th were issued a $0.045 dividend. This represents a $0.18 annualized dividend and a dividend yield of 1.44%. This is a boost from Lifevantage's previous quarterly dividend of $0.04. The ex-dividend date of this dividend was Friday, May 30th. Lifevantage's dividend payout ratio is currently 26.09%.

Institutional Investors Weigh In On Lifevantage

A number of hedge funds have recently made changes to their positions in LFVN. Cubist Systematic Strategies LLC acquired a new position in Lifevantage during the 1st quarter valued at about $97,000. Brown Advisory Inc. acquired a new position in shares of Lifevantage in the first quarter valued at about $150,000. Cannon Global Investment Management LLC acquired a new position in shares of Lifevantage in the first quarter valued at about $156,000. State of Wyoming acquired a new position in shares of Lifevantage in the first quarter valued at about $173,000. Finally, XTX Topco Ltd acquired a new position in shares of Lifevantage in the first quarter valued at about $186,000. 35.32% of the stock is currently owned by hedge funds and other institutional investors.

About Lifevantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.